AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 11 2021
News
Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19
Pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the Food and Drug Administration for molnupiravir, an antiviral drug that offers the promise that COVID-19 could soon be treated by a pill.
Molnupiravir, an orally ingested antiviral pill, is used to treat mild to moderate adult cases of COVID-19 that
USA TODAYDec 27 2021
News
Pfizer antiviral pill could be risky with other widely used medications
The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for COVID-19 that has been touted as a game changer in the fight against the pandemic.
However, experts told NBC News that the pills will require careful monitoring by doctors and pharmacists.
While Pfizer's Paxlovid has been
The HillNov 04 2021
News
UK Becomes First to Approve Antiviral Home Pill for COVID-19
Britain has become the first country to approve an antiviral COVID-19 treatment that can be taken as a pill at home.
The UK national medicines regulator, the MHRA, announced on Nov. 4 that the antiviral Lagevrio (molnupiravir) had been authorised to treat mild to moderate COVID-19—in those with other risk factors, such as obesity, diabetes, or those over 60 years old.
“Today is a
The Epoch TimesMar 02 2021
News
Biden: US will have enough COVID vaccines for every adult by the ‘end of May’
President Biden on Tuesday said that the US will now have enough COVID-19 vaccines for every adult “by the end of May” — and that the feds will start a new program aimed at vaccinating all teachers by the end of March.
The ambitious timeline — less than three months away — comes days after US health regulators approved a third vaccine, developed by Johnson & Johnson, which requires
New York Post (News)Nov 24 2021
News
US hospitals prepare for influx of Covid patients as millions travel for Thanksgiving
As cases begin surging once more in the US, millions of people are expected to travel for the Thanksgiving holiday, and health workers and hospital systems are now preparing for an influx of Covid patients after having little time to recover from the summer surge.
Last year, there was a major surge in cases around the holidays. But this year, new tools could blunt the spread – if they
The GuardianMar 02 2021
News
Biden promises vaccine supply for all US adults by end of May
The United States will have enough coronavirus vaccine doses for every adult in the country by the end of May, President Joe Biden announced on Tuesday, as production of a third vaccine is set to ramp up.
During a news conference at the White House, Biden said he had invoked a wartime production law to require pharmaceutical company Merck & Co to help produce a newly approved
Al JazeeraMar 04 2021
Opinion
Is the press too pessimistic about the pandemic?
YESTERDAY, PRESIDENT BIDEN gave a speech at the White House and said that the US is on track to have enough vaccine supply to cover every adult in America by the end of May—a two-month improvement on his administration’s previous timeline. Biden announced that the federal government has taken steps to accelerate the production of Johnson & Johnson’s vaccine, including helping to finalize a
Columbia Journalism ReviewNov 16 2021
Headline Roundup
Pfizer to Allow Generic Drugmakers to Manufacture COVID-19 Antiviral Pill
Pharmaceutical company Pfizer announced Tuesday that it would allow generic drug companies around the world to produce its COVID-19 antiviral pill by granting a royalty-free license to Medicines Patent Pool, a U.N.-backed nonprofit.
Merck made a similar arrangement for its COVID-19 pill last month. Pfizer also formally asked the FDA to grant emergency use authorization for its pill.
The Daily Wire Associated Press New York Times (News)Oct 13 2020
Opinion
Vaccine development process is safe, claims of the contrary are baseless
All of our lives have been drastically impacted by the ongoing coronavirus pandemic — and we know all of us are eager to return to the way things were before the pandemic began. However, that simply won’t be possible without a safe, effective vaccine. Fortunately, due to the strength of American innovation and unprecedented public-private partnerships, a COVID-19 vaccine is on the horizon. We
Multiple Writers - Lean RightDec 27 2021
Headline Roundup
Paxlovid, Pfizer's COVID-19 Pill, May Mix Poorly With Other Common Medications
According to a report from NBC News, experts are warning that new antiviral pills to treat COVID-19 may not be safe for everyone.
Pfizer's Paxlovid pills were authorized by the Food and Drug Administration (FDA) last week for high-risk individuals, but there are concerns about how the medication will mix with treatments for other ailments. A pharmaceutical scientist told NBC News that
Newsmax (News) NBC News (Online) The Hill